$TXMD 8-K/A SEC Filings

Filed On	Filing
06 Jan 2023	8-K/A: Departure/Election of Directors or Officers; Compensation Effective December 30, 2022 (the “Closing Date”), TherapeuticsMD, Inc., a Nevada corporation (the “Company”), completed its previously announced transaction (the “Transaction”) with Mayne Pharma LLC, a Delaware limited liability company ...
06 Jun 2022	8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year
16 Nov 2021	8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
03 Feb 2012	8-K/A: Changes in Registrant's Certifying Accountant
02 Feb 2012	8-K/A: Financial Statements and Exhibits
09 Dec 2011	8-K/A: Financial Statements and Exhibits
08 Dec 2011	8-K/A: Financial Statements and Exhibits
22 Nov 2011	8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more
15 Jun 2010	8-K/A: Financial Statements and Exhibits
06 Oct 2009	8-K/A: Changes in Registrant's Certifying Accountant
02 Jul 2008	8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation
13 Apr 2006	8-K/A: Changes in Registrant's Certifying Accountant

Comments